Home 2018-05-22T18:26:57+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

Ellie Williams @thesgconline solves the structure of the ALK2/FKBP12 complex bound to 2 novel chemical inhibitors. This will guide the design of drugs against #DIPG and #FOP. #Openscience notebook record: https://t.co/c2MnNLtg06 Accompanying blog: https://t.co/Ji4Hzrtqxo

Thank you to our partners @ReactionBiology who have joined us in our fight against #DIPG using #openscience #drugdiscovery

For the news release: https://t.co/FsFKeYYnSw

62 sour faces for #DIPG in under a minute! Impressive @BrainTumourOrg 👌👍👏 thank you for this #LemonFaceChallenge video and supporting children with this disease!

Nicolas Cage donates $10,000 to fight #DIPG. Very sad to lose another child to this disease. #Love4Sophia #sosostrong


Challenge completed!!! Team at SGC-Oxford responds to #lemonfacechallenge from Charles River @CRiverLabs @hamblin_nicole.
We nominate our friends at the @BrainTumourOrg David Jenkinson & colleagues! #DefeatDIPG @GroupBrennan @wenhwalee https://t.co/mKFZvdwFgE

Load More...

Latest Blog Posts